JP2023520591A5 - - Google Patents

Info

Publication number
JP2023520591A5
JP2023520591A5 JP2022560917A JP2022560917A JP2023520591A5 JP 2023520591 A5 JP2023520591 A5 JP 2023520591A5 JP 2022560917 A JP2022560917 A JP 2022560917A JP 2022560917 A JP2022560917 A JP 2022560917A JP 2023520591 A5 JP2023520591 A5 JP 2023520591A5
Authority
JP
Japan
Prior art keywords
hydroxyvitamin
days
subject
level
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022560917A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023520591A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/000220 external-priority patent/WO2021205225A1/en
Publication of JP2023520591A publication Critical patent/JP2023520591A/ja
Publication of JP2023520591A5 publication Critical patent/JP2023520591A5/ja
Pending legal-status Critical Current

Links

JP2022560917A 2020-04-06 2021-04-06 Ｓａｒｓ－ｃｏｖ－２感染症の治療のための２５－ヒドロキシビタミンｄ Pending JP2023520591A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US202063006034P 2020-04-06 2020-04-06
US63/006,034 2020-04-06
US202063006563P 2020-04-07 2020-04-07
US63/006,563 2020-04-07
US202063009155P 2020-04-13 2020-04-13
US63/009,155 2020-04-13
US202063012781P 2020-04-20 2020-04-20
US63/012,781 2020-04-20
US202063032714P 2020-05-31 2020-05-31
US63/032,714 2020-05-31
PCT/IB2021/000220 WO2021205225A1 (en) 2020-04-06 2021-04-06 25-hydroxyvitamin d for the treatment of sars-cov-2 infection

Publications (2)

Publication Number Publication Date
JP2023520591A JP2023520591A (ja) 2023-05-17
JP2023520591A5 true JP2023520591A5 (enExample) 2024-04-18

Family

ID=75904967

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022560917A Pending JP2023520591A (ja) 2020-04-06 2021-04-06 Ｓａｒｓ－ｃｏｖ－２感染症の治療のための２５－ヒドロキシビタミンｄ

Country Status (8)

Country Link
US (2) US20210308151A1 (enExample)
EP (1) EP4132477A1 (enExample)
JP (1) JP2023520591A (enExample)
KR (1) KR20220164539A (enExample)
CN (1) CN116033940A (enExample)
CA (1) CA3176559A1 (enExample)
TW (1) TW202203936A (enExample)
WO (1) WO2021205225A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2862462B2 (es) * 2020-04-06 2023-04-27 Servicio Andaluz De Salud Compuestos para la profilaxis y/o el tratamiento del sindrome de dificultad respiratoria aguda
CN120694962A (zh) * 2020-05-31 2025-09-26 艾尔金制药有限公司 硬胶囊剂型和其用途
CN116785295A (zh) * 2023-06-29 2023-09-22 吉林大学 雷特格韦在防治新型冠状病毒感染药物中的应用
WO2025094144A1 (en) 2023-11-02 2025-05-08 Eirgen Pharma Ltd. Controlling loss of kidney function

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264223A (en) 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5431917A (en) 1992-10-08 1995-07-11 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
FR2757173A1 (fr) 1996-12-17 1998-06-19 Warner Lambert Co Compositions polymeres d'origine non-animale pour la formation de films
KR100379674B1 (ko) 2000-03-06 2003-04-10 주식회사 서흥캅셀 펙틴과 글리세린의 배합용액을 이용한 셀룰로오스 캅셀 및그의 제조방법
ES2593047T3 (es) * 2006-02-03 2016-12-05 Opko Renal, Llc Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3
US20080031957A1 (en) 2006-05-15 2008-02-07 Deluca Hector F Pulmonary delivery of 1alpha,25-dihydroxyvitamin D3 and co-administration of parathyroid hormone or calcitonin
FR2902092B1 (fr) 2006-06-07 2008-09-05 Sapelem Soc Par Actions Simpli Appareil de manutention de charge
KR20190028822A (ko) * 2007-04-25 2019-03-19 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
JP2017523220A (ja) * 2014-08-07 2017-08-17 オプコ アイルランド グローバル ホールディングス リミテッド ２５−ヒドロキシビタミンｄを用いる補助的療法
JP7032322B2 (ja) * 2016-03-28 2022-03-08 オプコ アイルランド グローバル ホールディングス リミテッド ビタミンｄ治療法
JP7603000B2 (ja) 2018-08-31 2024-12-19 オプコ アイルランド グローバル ホールディングス リミテッド ビタミンｄ小児用剤形、製造方法および使用方法

Similar Documents

Publication Publication Date Title
JP2023520591A5 (enExample)
CN111265500B (zh) 一种防治covid-19的药物组合物及其制备方法
JP2017503801A (ja) 小児における急性呼吸促迫症候群の治療のための吸入一酸化窒素ガスを使用する方法
US11103500B2 (en) Use of levocetirizine and montelukast in the treatment of traumatic injury
JP2023527422A5 (enExample)
WO2021217702A1 (zh) 一种预防或治疗covid-19新冠肺炎的药物、食物及其应用
EP4137511A1 (en) New composition for use to treat and prevent infections by covid-19 and other coronaviruses
US11844771B2 (en) Methods of treating acute respiratory distress syndrome using colchicine
CN116459295A (zh) 一种肺炎清化方及其应用
US12178844B2 (en) Compositions for treating autoimmune arthritis
CN1852723A (zh) 天竺葵种提取物的用途
WO2024078507A1 (zh) 麦角甾醇在制备防治胃溃疡药物中的应用
US20230270724A1 (en) PDE3 inhibitors for treating viral infections
RU2772701C1 (ru) Способы лечения инфекционных заболеваний, вызванных коронавирусом
EP4051307B1 (en) Peptide for prevention or treatment of covid-19
CN118236359B (zh) 硫酸特布他林在防治肠缺血再灌注损伤中的应用
CN118845997A (zh) 一种选择性TNFR1拮抗肽Hydrostatin-SN61-4G在治疗脓毒症及防重症转化中的应用
CN111214495B (zh) 注射用母牛分枝杆菌在制备用于防治呼吸系rsv感染的药物中的应用
CN113289011A (zh) 新型冠状病毒肺炎的治疗方法
WO2025104696A1 (en) Pharmaceutical composition comprising edaravone for use in reducing levels of il-6 and tnf-alpha inflammatory markers and reducing time to withdrawal of oxygen therapy in patients with infectious diseases
KR20240009157A (ko) 바이러스 감염증 치료용 약학 조성물 및 치료 방법
CN119258136A (zh) 中药组合物在制备止咳化痰的药物中的应用
CN114159474A (zh) 六神丸在制备治疗真菌性肺炎的药物中的应用
CN1164325C (zh) 抗炎顺气胶囊
CN116635058A (zh) 抗病毒剂